Castle Biosciences, Inc. 2026 Q1 - Results - Earnings Call Presentation
Castle Biosciences Inc CSTL
$19.13
▲ +1.32%
(+$0.25)
Open
$18.69
Prev Close
$18.88
Day Range
$18.64 – $19.61
52W Range
$14.59 – $44.28
Market Cap
$580.21M
Beta
1.08
EPS (TTM)
$-0.43
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-07-25 |
| Shares Out. | 30,300,000 |
| Website | castlebiosciences.com/ ↗ |
| Phone | 13026365400 |
Castle Biosciences Inc is a publicly traded company under the ticker symbol CSTL on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for CSTL
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
BTIG Maintains Buy on Castle Biosciences, Lowers Price Target to $40
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
Baird Maintains Outperform on Castle Biosciences, Lowers Price Target to $43
Castle Biosciences, Inc. (CSTL) Q1 2026 Earnings Call Transcript
Transcript : Castle Biosciences, Inc., Q1 2026 Earnings Call, May 06, 2026
Castle Biosciences, Inc. Q1 2026 Earnings Call Summary